UM Ventures announces license deals

University of Maryland Ventures, a joint research commercialization effort of the University of Maryland, Baltimore, and the University of Maryland, College Park, announced license and/or option agreements with five life sciences companies across the Baltimore-Washington region. The companies are Rexahn Pharmaceuticals Inc., of Rockville; IGI Technologies Inc., of Elkridge; Plasmonix Inc., of Arbutus; A&G Pharmaceuticals Inc., ...

Leave a Reply

Your email address will not be published. Required fields are marked *